202 related articles for article (PubMed ID: 11395239)
1. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
Glaser CM; Millesi W; Kornek GV; Lang S; Schüll B; Watzinger F; Selzer E; Lavey RS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):705-15. PubMed ID: 11395239
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
Dusenbery KE; McGuire WA; Holt PJ; Carson LF; Fowler JM; Twiggs LB; Potish RA
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1079-84. PubMed ID: 8083076
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin increases hemoglobin in cancer patients during radiation therapy.
Lavey RS; Dempsey WH
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1147-52. PubMed ID: 8262840
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
[TBL] [Abstract][Full Text] [Related]
5. Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer.
Thomas G; Ali S; Hoebers FJ; Darcy KM; Rodgers WH; Patel M; Abulafia O; Lucci JA; Begg AC
Gynecol Oncol; 2008 Feb; 108(2):317-25. PubMed ID: 18037478
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of hemoglobin concentration in the course of chemoradiotherapy of patients with oropharyngeal squamous cell carcinoma].
Semin DY; Mardynsky YS; Medvedev SV; Isaev PA; Derbugov DN; Polkin VV; Radzhapova MU; Vasilkov SV
Vopr Onkol; 2015; 61(1):125-9. PubMed ID: 26016158
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach V; Stromberger C; Poettgen C; Baumann M; Budach W; Grabenbauer G; Marnitz S; Olze H; Wernecke KD; Ghadjar P
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):916-24. PubMed ID: 25670541
[TBL] [Abstract][Full Text] [Related]
8. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
[TBL] [Abstract][Full Text] [Related]
9. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with pathologic T0N+ oral and oropharyngeal cancer after neoadjuvant therapy and surgery: the minority report.
Perisanidis C; Sulzbacher I; Mittlböck M; Mitchell D; Czembirek C; Seemann R; Ewers R; Schopper C; Selzer E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):293-8. PubMed ID: 22939322
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Kunikane H; Watanabe K; Fukuoka M; Saijo N; Furuse K; Ikegami H; Ariyoshi Y; Kishimoto S
Int J Clin Oncol; 2001 Dec; 6(6):296-301. PubMed ID: 11828949
[TBL] [Abstract][Full Text] [Related]
12. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx.
Giralt JL; Gonzalez J; del Campo JM; Maldonado J; Sanz X; Pamias J; Eraso A; Bescos S; Raspall G
Cancer; 2000 Sep; 89(5):939-45. PubMed ID: 10964322
[TBL] [Abstract][Full Text] [Related]
13. [Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome].
Eckardt A; Rades D; Rudat V; Hofele C; Dammer R; Dietl B; Wildfang I; Karstens JH
Mund Kiefer Gesichtschir; 2002 Mar; 6(2):117-21. PubMed ID: 12017874
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
15. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).
Mohr C; Bohndorf W; Carstens J; Härle F; Hausamen JE; Hirche H; Kimmig H; Kutzner J; Mühling J; Reuther J
Int J Oral Maxillofac Surg; 1994 Jun; 23(3):140-8. PubMed ID: 7930766
[TBL] [Abstract][Full Text] [Related]
17. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
18. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
[TBL] [Abstract][Full Text] [Related]
19. Combined modality treatment of advanced cancers of the oral cavity and oropharynx.
Dobrowsky W; Dobrowsky E; Strassl H; Braun O; Gritzmann N; Scheiber V
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):239-42. PubMed ID: 1899411
[TBL] [Abstract][Full Text] [Related]
20. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
